Chargement en cours...
Challenging the standard of care in advanced melanoma: focus on pembrolizumab
The last several years have seen a dramatic rise in the number of effective therapies that have been shown to improve survival outcomes for patients with advanced melanoma. Among these treatments are the immune checkpoint inhibitors, a new class of immunotherapy, that have demonstrated the ability t...
Enregistré dans:
| Publié dans: | Cancer Manag Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626384/ https://ncbi.nlm.nih.gov/pubmed/29026335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S92546 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|